Jim Cramer reviewed top stocks on Mad Money, emphasizing AI's potential but cautioning against inflated claims. He believes AI can enhance customer service and predicts its impact on healthcare and transportation. Pfizer Inc. is ranked 4th on his list, praised for its growth potential and shareholder value.